Dark Forest Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.3K | Buy |
18,806
+5,161
| +38% | +$8.88K | ﹤0.01% | 1132 |
|
2025
Q1 | $45.4K | Sell |
13,645
-3,257
| -19% | -$10.8K | ﹤0.01% | 1183 |
|
2024
Q4 | $125K | Sell |
16,902
-7,859
| -32% | -$58.2K | 0.02% | 844 |
|
2024
Q3 | $233K | Sell |
24,761
-20,097
| -45% | -$189K | 0.03% | 800 |
|
2024
Q2 | $360K | Buy |
+44,858
| New | +$360K | 0.07% | 387 |
|
2024
Q1 | – | Sell |
-11,703
| Closed | -$95.1K | – | 730 |
|
2023
Q4 | $95.1K | Sell |
11,703
-10,089
| -46% | -$82K | 0.01% | 410 |
|
2023
Q3 | $99.2K | Sell |
21,792
-14,589
| -40% | -$66.4K | 0.01% | 1050 |
|
2023
Q2 | $256K | Buy |
36,381
+33,742
| +1,279% | +$238K | 0.02% | 867 |
|
2023
Q1 | $16.1K | Buy |
2,639
+1,834
| +228% | +$11.2K | ﹤0.01% | 988 |
|
2022
Q4 | $5.14K | Buy |
+805
| New | +$5.14K | ﹤0.01% | 859 |
|
2022
Q3 | – | Sell |
-40
| Closed | – | – | 1268 |
|
2022
Q2 | $0 | Buy |
+40
| New | – | ﹤0.01% | 1114 |
|
2022
Q1 | – | Sell |
-296
| Closed | -$6K | – | 1518 |
|
2021
Q4 | $6K | Buy |
+296
| New | +$6K | ﹤0.01% | 1097 |
|